3-(Benzyl-methyl-amino)-phenol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(Benzyl-methyl-amino)-phenol
• 英文别名: 3-(Benzyl(methyl)amino)phenol；3-[benzyl(methyl)amino]phenol
• 化学式: C₁₄H₁₅NO
• 分子量: 213.279
• InChiKey: FDVMHAOFOMUTEQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(Benzyl-methyl-amino)-phenol 在 哌啶 、 溶剂黄146 、 三氯氧磷 作用下， 以 乙醇 为溶剂， 反应 0.33h， 生成 7ACC2
  参考文献：
  名称：

  合成和评估11 C标记的香豆素类似物作为检测单羧酸盐转运蛋白表达的成像探针

  摘要：

  肿瘤中上调的单羧酸盐转运蛋白（MCT）被认为是诊断成像目标。在这里，我们合成了正电子发射断层扫描探针候选香豆素类似物2和3，并显示2对MCT的亲和力是代表性MCT抑制剂的55倍。尽管[ 11 C] 2显示出低的肿瘤聚集，可能是由于血浆蛋白形成加合物，而[ 11 C] 2显示出高的初始大脑摄取，这表明2的支架具有在星形胶质细胞-神经元成像探针中优选的特性乳酸穿梭。虽然进一步优化2 是必需的，我们的发现可用于指导以MCT为靶标的成像剂的开发。

  DOI：

  10.1016/j.bmcl.2017.09.033
• 作为产物：
  描述：

  3-[benzyl(methyl)amino]-2-chlorocyclohex-2-en-1-one 在 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙腈 为溶剂， 反应 42.0h， 以66%的产率得到3-(Benzyl-methyl-amino)-phenol
  参考文献：
  名称：

  由环己烷-1,3-二酮形成3-氨基酚

  摘要：

  在室温下，MeCN中DBU对3-氨基-2-氯环己-2--2-烯-1-酮的作用形成间位氨基酚。用易制备的卤化剂BnNMe 3 ·ICl 2在MeOH-CH 2 Cl 2中处理3-氨基环己-2-烯-1-酮可生成氯化合物。氨基必须带有两个取代基：两个芳基，一个芳基和一个烷基或两个烷基。这种类型的3-氨基环己-2-烯-1-酮很容易由环​​己-2-烯-1-酮和伯或仲胺制得。

  DOI：

  10.1021/acs.joc.0c02284

文献信息

• [EN] 3-CARBOXY SUBSTITUTED COUMARIN DERIVATIVES WITH A POTENTIAL UTILITY FOR THE TREATMENT OF CANCER DISEASES<br/>[FR] DÉRIVÉS DE COUMARINE 3-CARBOXY SUBSTITUÉS PRÉSENTANT UNE UTILITÉ POTENTIELLE DANS LE TRAITEMENT DES MALADIES CANCÉREUSES
  申请人：UNIV CATHOLIQUE LOUVAIN

  公开号：WO2014195507A1

  公开（公告）日：2014-12-11

  The present invention relates to novel compounds. The present invention also relates to the compounds for use as a medicine, more in particular for the prevention or treatment of cancer, more in particular cancers expressing MCT1 and/or MCT4. The present invention also relates to a method for the prevention or treatment of cancer in animals or humans by using the novel compounds. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds and to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of cancer. The present invention also relates to processes for the preparation of the compounds.

  本发明涉及新化合物。本发明还涉及用作药物的化合物，更具体地用于预防或治疗癌症，更具体地是表达MCT1和/或MCT4的癌症。本发明还涉及一种通过使用新化合物预防或治疗动物或人类癌症的方法。本发明还涉及新化合物的药物组合物或联合制剂，以及用作药物的组合物或制剂，更优选地用于预防或治疗癌症。本发明还涉及制备这些化合物的方法。
• [EN] HISTONE DEMETHYLASE INHIBITORS<br/>[FR] INHIBITEURS DE L'HISTONE DÉMÉTHYLASE
  申请人：QUANTICEL PHARMACEUTICALS INC

  公开号：WO2016044429A1

  公开（公告）日：2016-03-24

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrido[3,4-d]pyrimidin-4-one derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

  本发明通常涉及治疗癌症和肿瘤性疾病的组合物和方法。本文提供了替代的吡啶并[3,4-d]嘧啶-4-酮衍生物化合物和包含该化合物的药物组合物。所述化合物和组合物对组蛋白去甲基化酶的抑制有用。此外，所述化合物和组合物对于治疗癌症，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等方面是有用的。
• Dinuclear zinc-catalyzed asymmetric Friedel–Crafts alkylation/cyclization of 3-aminophenols with α,α-dicyanoolefins
  作者：Hang Yan、Shi-Kun Jia、Yu-Huan Geng、Jiao-Jiao Han、Yuan-Zhao Hua、Min-Can Wang

  DOI：10.1039/d1cc04177k

  日期：——

  An enantioselective Friedel–Crafts alkylation/cyclization tandem reaction of 3-aminophenols with α,α-dicyanoolefins has been performed successfully using a chiral dinuclear zinc catalyst, leading to a range of chiral 2-amino-4H-chromenes (up to 98% yield and >99% ee). To the best of our knowledge, this is the first asymmetric example of the dinuclear zinc-catalysed functionalization of aromatic C(sp2)–H

  使用手性双核锌催化剂成功地进行了 3-氨基苯酚与 α,α-二氰基烯烃的对映选择性 Friedel-Crafts 烷基化/环化串联反应，产生了一系列手性 2-氨基-4 H-色烯（高达 98%）产率和 >99% ee）。据我们所知，这是第一个双核锌催化芳族 C(sp 2 )-H 键功能化的不对称例子。
• HISTONE DEMETHYLASE INHIBITORS
  申请人：Celgene Quanticel Research, Inc.

  公开号：US20160194323A1

  公开（公告）日：2016-07-07

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrido[3,4-d]pyrimidin-4-one derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer, melanoma, and the like.

  本发明涉及治疗癌症和肿瘤疾病的组合物和方法。本文提供了取代的吡啶并[3,4-d]嘧啶-4-酮衍生物化合物及包含该化合物的制药组合物。所述化合物和组合物对组蛋白去甲基化酶的抑制具有用途。此外，所述化合物和组合物对治疗癌症，如前列腺癌，乳腺癌，膀胱癌，肺癌，黑色素瘤等具有用途。
• 3-CARBOXY SUBSTITUTED COUMARIN DERIVATIVES WITH A POTENTIAL UTILITY FOR THE TREATMENT OF CANCER DISEASES
  申请人：UNIVERSITE CATHOLIQUE DE LOUVAIN

  公开号：US20160115146A1

  公开（公告）日：2016-04-28

  The present invention relates to novel compounds. The present invention also relates to the compounds for use as a medicine, more in particular for the prevention or treatment of cancer, more in particular cancers expressing MCT1 and/or MCT4. The present invention also relates to a method for the prevention or treatment of cancer in animals or humans by using the novel compounds. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds and to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of cancer. The present invention also relates to processes for the preparation of the compounds.

  本发明涉及新颖化合物。本发明还涉及用于药物的化合物，更具体地用于预防或治疗癌症，更具体地用于表达MCT1和/或MCT4的癌症。本发明还涉及使用新颖化合物预防或治疗动物或人类癌症的方法。本发明还涉及新颖化合物的制药组合物或复方制剂，以及用于药物的组合物或制剂，更优选用于预防或治疗癌症。本发明还涉及制备这些化合物的方法。